Search

The UT Southwestern medical student met with patients as part of the Hospital Elder Life Program (HELP), a joint effort between UTSW and the Hobson Wildenthal Honors College at the University of Texas at Dallas that sends student volunteers to help geriatric patients retain their cognitive skills

UT Southwestern Medical Center researchers have identified a gene called Lipe that appears to be pivotal to retinal health, with mutations spurring immune activation and retinal degeneration. This is important because the retina is responsible for detecting the light that is transformed into vision.

A consortium of government, industry, and nonprofit partners will fund gene therapy clinical trials for three different rare diseases at UT Southwestern Medical Center and Children’s Health, where scientists are working on gene therapies to treat neurodevelopmental disorders in children.

UT Southwestern Medical Center and its William P. Clements Jr. University Hospital have been named an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America (IDSA), recognizing a commitment to reducing infections caused by antimicrobial resistance.

Pregnant individuals should be careful regarding energy drinks and their overall intake of caffeine, according to an expert at UT Southwestern Medical Center.

Peter Roland, M.D., Professor Emeritus of Otolaryngology-Head and Neck Surgery at UT Southwestern Medical Center, has been honored by the American Cochlear Implant Alliance with its 2023 Lifetime Achievement Award for his groundbreaking work in advancing the use and benefits of cochlear implants (CI

About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or “jumping genes,” from hopping around the human genome.

Immunotherapy drugs that target a protein called programmed death ligand 1 (PD-L1) on the surface of cancer cells have quickly become a mainstay to treat many forms of cancer, often with dramatic results.

A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial with UT Southwestern as the lead enrolling site.

UT Southwestern researchers have determined how circulating “bad cholesterol” enters artery walls to cause the plaque that narrows the blood vessels and leads to heart attacks and strokes.